The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)

The advancement of new therapies, including targeted therapies and immunotherapies, has improved the survival of non-small-cell lung cancer (NSCLC) patients in the last decade. Some NSCLC patients still do not benefit from therapies or encounter progressive disease during the course of treatment bec...

Full description

Bibliographic Details
Main Authors: Ping-Chih Hsu, Cheng-Ta Yang, David M. Jablons, Liang You
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
proto-oncogene tyrosine-protein kinase Src
yes-associated protein (YAP)
Hippo pathway
non-small cell lung cancer (NSCLC)
tyrosine-kinase inhibitor (TKI)
YES1
Online Access:https://www.mdpi.com/2072-6694/12/6/1361

Internet

https://www.mdpi.com/2072-6694/12/6/1361

Similar Items